N-methyl-D-aspartate receptor antibody-associated movement disorder without encephalopathy

Developmental Medicine and Child Neurology

Volumn 56, Issue 2, 2014, Pages 190-193

  Hacohen, Yael ^a   Dlamini, Nomazulu ^b   Hedderly, Tammy ^b   Hughes, Elaine ^b   Woods, Martin ^b   Vincent, Angela ^a   Lim, Ming ^a,b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; DOUBLE STRANDED DNA ANTIBODY; GRANULOCYTE ANTIBODY; IMMUNOGLOBULIN; IMMUNOGLOBULIN M; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PREDNISOLONE; RHEUMATOID FACTOR;

ANTIBODY DETECTION; ARTICLE; CASE REPORT; CHILD; CHOREA; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; DYSTONIA; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FOLLOW UP; HUMAN; IMMUNOTHERAPY; MALE; MOTOR COORDINATION; MOTOR DYSFUNCTION; MYOCLONUS; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SCHOOL CHILD; SPEECH DISORDER; STEROID THERAPY; TREATMENT DURATION;

ABDOMEN; ADOLESCENT; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; AUTOANTIBODIES; AUTOIMMUNE DISEASES; CHILD; CHILD, PRESCHOOL; CHOREA; FEMALE; FOLLOW-UP STUDIES; GRANULOCYTES; HUMANS; IMMUNOGLOBULIN M; IMMUNOSUPPRESSIVE AGENTS; MALE; MOVEMENT DISORDERS; MYOCLONUS; PREDNISOLONE; RECEPTORS, N-METHYL-D-ASPARTATE; RECURRENCE;

EID: 84892483602     PISSN: 00121622     EISSN: 14698749     Source Type: Journal    
DOI: 10.1111/dmcn.12321     Document Type: Article

References (24)

1. Dale RC, Brilot F. Autoimmune basal ganglia disorders. J Child Neurol 2012; 27: 1470-81.
2. Brilot F, Merheb V, Ding A, et al. Antibody binding to neuronal surface in Sydenham chorea, but not in PANDAS or Tourette syndrome. Neurology 2011; 76: 1508-13.
3. Dale RC, Merheb V, Pillai S, et al. Antibodies to surface dopamine-2 receptor in autoimmune movement and psychiatric disorders. Brain 2012; 135: 3453-68.
4. Lancaster E, Dalmau J. Neuronal autoantigens-pathogenesis, associated disorders and antibody testing. Nat Rev Neurol 2012; 8: 380-90.
5. Armangue T, Petit-Pedrol M, Dalmau J. Autoimmune encephalitis in children. J Child Neurol 2012; 27: 1460-9.
6. Dalmau J, Lancaster E, Martinez-Hernandez E, Rosenfeld MR, Balice-Gordon R. Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol 2011; 10: 63-74.
7. Dale RC, Singh H, Troedson C, et al. A prospective study of acute movement disorders in children. Dev Med Child Neurol 2010; 52: 739-48.
8. Hacohen Y, Wright S, Waters P, et al. Paediatric autoimmune encephalopathies: clinical features, laboratory investigations and outcomes in patients with or without antibodies to known central nervous system autoantigens. J Neurol Neurosurg Psychiatry 2013; 84: 748-55.
9. Armangue T, Titulaer MJ, Málaga I, et al. Pediatric anti-N-methyl-D-aspartate receptor encephalitis - clinical analysis and novel findings in a series of 20 patients. J Pediatr 2013; 162: 850-6.
10. Florance NR, Davis RL, Lam C, et al. Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis in children and adolescents. Ann Neurol 2009; 66: 11-8.
11. Paoletti P, Neyton J. NMDA receptor subunits: function and pharmacology. Curr Opin Pharmacol 2007; 7: 39-47.
12. Kleinig TJ, Thompson PD, Matar W, et al. The distinctive movement disorder of ovarian teratoma-associated encephalitis. Mov Disord 2008; 23: 1256-61.
13. Baizabal-Carvallo JF, Stocco A, Muscal E, et al. The spectrum of movement disorders in children with anti-NMDA receptor encephalitis. Mov Disord 2013; 28: 543-7.
14. Dale RC, Irani SR, Brilot F, et al. N-methyl-D-aspartate receptor antibodies in pediatric dyskinetic encephalitis lethargica. Ann Neurol 2009; 66: 704-9.
15. Titulaer MJ, McCracken L, Gabilondo I, et al. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol 2013; 12: 157-65.
16. Rubio-Agustí I, Dalmau J, Sevilla T, Burgal M, Beltrán E, Bataller L. Isolated hemidystonia associated with NMDA receptor antibodies. Mov Disord 2011; 26: 351-2.
17. Masdeu JC, González-Pinto A, Matute C, et al. Serum IgG antibodies against the NR1 subunit of the NMDA receptor not detected in schizophrenia. Am J Psychiatry 2012; 169: 1120-1.
18. Brenner T, Sills GJ, Hart Y, et al. Prevalence of neurologic autoantibodies in cohorts of patients with new and established epilepsy. Epilepsia 2013; 54: 1028-35.
19. Tofaris GK, Irani SR, Cheeran BJ, et al. Immunotherapy-responsive chorea as the presenting feature of LGI1-antibody encephalitis. Neurology 2012; 79: 195-6.
20. Irani SR, Michell AW, Lang B, et al. Faciobrachial dystonic seizures precede Lgi1 antibody limbic encephalitis. Ann Neurol 2011; 69: 892-900.
21. Dale RC, Yin K, Ding A, et al. Antibody binding to neuronal surface in movement disorders associated with lupus and antiphospholipid antibodies. Dev Med Child Neurol 2011; 53: 522-8.
22. Lapteva L, Nowak M, Yarboro CH, et al. Anti-N-methyl-D-aspartate receptor antibodies, cognitive dysfunction, and depression in systemic lupus erythematosus. Arthritis Rheum 2006; 54: 2505-14.
23. Roze E, Bounolleau P, Ducreux D, et al. Propriospinal myoclonus revisited: clinical, neurophysiologic, and neuroradiologic findings. Neurology 2009; 72: 1301-9.
24. DiFazio MP, Morales J, Davis R. Acute myoclonus secondary to group A beta-hemolytic streptococcus infection: a PANDAS variant. J Child Neurol 1998; 13: 516-8.